But did you look at the balance sheet? This company has currently the market cap of a shell and just 200M shares issued, while having more than 1M$ in revenues, a net income and a cash flow that is going to become positive as soon as a few revenues from the LifeStem operations come in (and they already started cell collection, as advertised on magazines).
The otc is full of pos trading at a 100 times bigger market cap.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.